Live feed/
Filings
/
SCHEDULE
/
0001104659-25-014026
Stake: 10.90%
Shares: 393,615,130
CUSIP: N82405106
Class: Common Shares, nominal value EUR0.01 per share
Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: All of the Common Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Common Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Common Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein. Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
24 filings by this filer
23 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 5.56
109,835,654 shares short · +9.1% vs prior
Institutional Consensus · 2026-03-31
Held by elite portfolio managers
2 holders · $201.34M
Point72 Asset MgmtViking Global
Post-Filing Returns · since 2025-02-14 on STLA
Anchor price 5.65 on closest trading day on/after 2025-02-14. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Other 13D/G Filings on Stellantis N.V.
| Filed | Form | Filer | Stake | Shares | |
| 2024-01-29 |
SC |
Bpifrance Participations SA |
— |
— |
view → |
| 2024-01-22 |
SC |
Exor N.V. |
— |
— |
view → |
| 2021-04-15 |
SC |
Peugeot Brothers Holdings |
— |
— |
view → |
| 2021-04-15 |
SC |
Exor N.V. |
— |
— |
view → |
| 2021-02-03 |
SC |
Exor N.V. |
— |
— |
view → |
Other Filings by Bpifrance Participations SA
| Filed | Form | Issuer | Stake | Shares | |
| 2026-05-28 |
SCHEDULE 13D/A |
Constellium SE CSTM |
6.20% |
8,403,903 |
view → |
| 2026-05-12 |
SCHEDULE 13D/A |
Valneva SE VALN |
— |
14,317,670 |
view → |
| 2026-01-07 |
SCHEDULE |
DBV Technologies S.A. DBVTF |
4.70% |
10,898,595 |
view → |
| 2026-01-05 |
SCHEDULE |
DBV Technologies S.A. DBVTF |
5.30% |
10,985,372 |
view → |
| 2025-01-30 |
SCHEDULE |
Cellectis S.A. CLLS |
13.10% |
10,292,653 |
view → |
| 2024-01-29 |
SC |
Stellantis N.V. STLA |
— |
— |
view → |
| 2022-12-06 |
SC |
Innate Pharma SA IPHYF |
— |
— |
view → |
| 2022-10-21 |
SC |
Innate Pharma SA IPHYF |
— |
— |
view → |
| 2022-06-28 |
SC |
VectivBio Holding AG |
— |
— |
view → |
| 2022-03-17 |
SC |
SEQUANS COMMUNICATIONS SQNS |
— |
— |
view → |
| 2022-01-11 |
SC |
Technip Energies N.V. |
— |
— |
view → |
| 2021-11-18 |
SC |
TechnipFMC plc FTI |
— |
— |
view → |
| 2021-08-09 |
SC |
SEQUANS COMMUNICATIONS SQNS |
— |
— |
view → |
| 2021-05-11 |
SC |
Technip Energies N.V. |
— |
— |
view → |
| 2021-04-01 |
SC |
TechnipFMC plc FTI |
— |
— |
view → |
| 2021-02-12 |
SC |
Cellectis S.A. CLLS |
— |
— |
view → |
| 2021-02-12 |
SC |
SEQUANS COMMUNICATIONS SQNS |
— |
— |
view → |
| 2021-02-12 |
SC |
DBV Technologies S.A. DBVTF |
— |
— |
view → |
| 2019-12-16 |
SC |
Millendo Therapeutics, Inc. TPST |
— |
— |
view → |
| 2019-10-15 |
SC |
DBV Technologies S.A. DBVTF |
— |
— |
view → |
Showing 20 of 23
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →